J7601 Ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form, 3 mg
Short descriptor: Ensifentrine inh 3 mg
Look up J7601 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.
J7601 is the HCPCS Level II code for Ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form, 3 mg (2026). It belongs to Section J — Drugs Administered Other Than Oral Method. Under Medicare, its coverage status is: Carrier judgment. Part B pricing methodology: Drugs.
Classification & CMS Attributes
- Medicare Coverage
- Carrier judgment (code C)
- Part B Pricing
- Drugs (indicator 51)
- Type of Service
- Medical care
- Effective Date
- 2025-01-01
- 2026 Maintenance
- No change this year
Drug Details
- Drug / Substance
- Ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form
- Dose / Unit
- 3 mg
See the full HCPCS Table of Drugs (J-codes).
References
Cite This Page
Reference J7601 with the canonical source and edition:
J7601 — Ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form, 3 mg. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/J7601
Canonical URL: https://icd10codingpro.com/hcpcs-codes/J7601